Skip to main content
PMC home page
Gut logoLink to Gut
. 1996 Apr;38(4):616–618. doi: 10.1136/gut.38.4.616

Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation.

F W Leebeek 1, R J Ouwendijk 1, A H Kolk 1, A Dees 1, J C Meek 1, J E Nienhuis 1, A M Dingemans-Dumas 1
PMCID: PMC1383125  PMID: 8707098

Abstract

BACKGROUND--Bladder instillations with Bacillus Calmette-Guerin (BCG) are commonly used as immunotherapy for bladder carcinoma. Sometimes patients experience serious systemic side effects, such as sepsis or pneumonitis. Granulomatous hepatitis is a rare serious side effect, which has been considered a hypersensitivity reaction to BCG. PATIENT--The first case of granulomatous hepatitis after BCG bladder instillation in which mycobacteria were identified by staining techniques and mycobacterial DNA was detected in liver tissue using the polymerase chain reaction is reported. CONCLUSION--The granulomatous hepatitis was caused by BCG infection of the liver after haematogenous dissemination of BCG, rather than hypersensitivity.

Full text

PDF

Images in this article

617p617-a
on p.617

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boom R., Sol C. J., Salimans M. M., Jansen C. L., Wertheim-van Dillen P. M., van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990 Mar;28(3):495–503. doi: 10.1128/jcm.28.3.495-503.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Kolk A. H., Noordhoek G. T., de Leeuw O., Kuijper S., van Embden J. D. Mycobacterium smegmatis strain for detection of Mycobacterium tuberculosis by PCR used as internal control for inhibition of amplification and for quantification of bacteria. J Clin Microbiol. 1994 May;32(5):1354–1356. doi: 10.1128/jcm.32.5.1354-1356.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kolk A. H., Schuitema A. R., Kuijper S., van Leeuwen J., Hermans P. W., van Embden J. D., Hartskeerl R. A. Detection of Mycobacterium tuberculosis in clinical samples by using polymerase chain reaction and a nonradioactive detection system. J Clin Microbiol. 1992 Oct;30(10):2567–2575. doi: 10.1128/jcm.30.10.2567-2575.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kox L. F., Rhienthong D., Miranda A. M., Udomsantisuk N., Ellis K., van Leeuwen J., van Heusden S., Kuijper S., Kolk A. H. A more reliable PCR for detection of Mycobacterium tuberculosis in clinical samples. J Clin Microbiol. 1994 Mar;32(3):672–678. doi: 10.1128/jcm.32.3.672-678.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kristjansson M., Green P., Manning H. L., Slutsky A. M., Brecher S. M., von Reyn C. F., Arbeit R. D., Maslow J. N. Molecular confirmation of bacillus Calmette-Guérin as the cause of pulmonary infection following urinary tract instillation. Clin Infect Dis. 1993 Aug;17(2):228–230. doi: 10.1093/clinids/17.2.228. [DOI] [PubMed] [Google Scholar]
  6. Lamm D. L., van der Meijden P. M., Morales A., Brosman S. A., Catalona W. J., Herr H. W., Soloway M. S., Steg A., Debruyne F. M. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol. 1992 Mar;147(3):596–600. doi: 10.1016/s0022-5347(17)37316-0. [DOI] [PubMed] [Google Scholar]
  7. Marans H. Y., Bekirov H. M. Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma. J Urol. 1987 Jan;137(1):111–112. doi: 10.1016/s0022-5347(17)43892-4. [DOI] [PubMed] [Google Scholar]
  8. McParland C., Cotton D. J., Gowda K. S., Hoeppner V. H., Martin W. T., Weckworth P. F. Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Guérin immunotherapy. Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1330–1333. doi: 10.1164/ajrccm/146.5_Pt_1.1330. [DOI] [PubMed] [Google Scholar]
  9. Molina J. M., Rabian C., D'Agay M. F., Modai J. Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guerin: successful treatment with steroids. J Urol. 1992 Mar;147(3):695–697. doi: 10.1016/s0022-5347(17)37354-8. [DOI] [PubMed] [Google Scholar]
  10. Proctor D. D., Chopra S., Rubenstein S. C., Jokela J. A., Uhl L. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma. Am J Gastroenterol. 1993 Jul;88(7):1112–1115. [PubMed] [Google Scholar]
  11. Steg A., Leleu C., Debré B., Boccon-Gibod L., Sicard D. Systemic bacillus Calmette-Guérin infection, 'BCGitis', in patients treated by intravesical bacillus Calmette-Guérin therapy for bladder cancer. Eur Urol. 1989;16(3):161–164. doi: 10.1159/000471561. [DOI] [PubMed] [Google Scholar]
  12. Thompson D., Cumming J. Granulomatous hepatitis following intravesical BCG therapy. Br J Urol. 1990 Oct;66(4):432–433. doi: 10.1111/j.1464-410x.1990.tb14971.x. [DOI] [PubMed] [Google Scholar]
  13. Witjes J. A., vd Meijden A. P., Debruyne F. M. Use of intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview. Urol Int. 1990;45(3):129–136. doi: 10.1159/000281694. [DOI] [PubMed] [Google Scholar]
  14. Witjes J. A., vd Meijden A. P., Debruyne F. M. Use of intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview. Urol Int. 1990;45(3):129–136. doi: 10.1159/000281694. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES